1Askling J fored CM,Brandt L, Baecklund E,et al. Risk and Casecharacteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden[J]. Arthritis Rheum, 2005,52:1986-1992.
2Giles JT,Bathon JM. Serious Infections associated with anticytokine therapies in the rheumatic diseases[J]. J Intensive Care Med,2004, 19 : 320-333.
3Hyrich KL,Watson KD,Silman AJ,et al. Predictors of response to anti-TNF-therapy among patients with rheumatoid arthritis: results from the British Society for rheumatelogy biologics register[J]. Rheumatology, 2006,45 : 1558-1567.
4Van Der Heijde D, Klareskog L, Rodriguez-Valverde V, et al. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group.Infliximab and methotrexate in the treatment of rheumatoid arthritis[J]. N Engl J Med, 2000,343 : 1594-1602.
2Askling J, Fored CM, Brandt L, Baecklund E, et al. Risk and Casechar- acteristlcs oftuberculosisin rheumatoid arthritis associatedwith tumor necro- sis factor antagonists in Sweden [J]. Arthritis Rheum, 2005,52:1986- 1992.
3Giles JT, Bathon JM. Serious Infections associated with anticytokine therapies in the rheumatic diseases [J]. J Intensive Care Med,2004,19: 320-333.
